Donoghue Forlines’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,338
| Closed | -$594K | – | 245 |
|
|
2024
Q2 | $594K | Buy |
+4,338
| New | +$594K | 0.17% | 137 |
|
|
2023
Q1 | – | Sell |
-6,502
| Closed | -$1.02M | – | 227 |
|
|
2022
Q4 | $1.02M | Buy |
6,502
+2,777
| +75% | +$434K | 0.36% | 85 |
|
|
2022
Q3 | $457K | Buy |
3,725
+9
| +0.2% | +$1.1K | 0.16% | 106 |
|
|
2022
Q2 | $494K | Sell |
3,716
-4,499
| -55% | -$598K | 0.13% | 223 |
|
|
2022
Q1 | $1.12M | Buy |
8,215
+951
| +13% | +$130K | 0.24% | 110 |
|
|
2021
Q4 | $1.26M | Sell |
7,264
-128
| -2% | -$22.2K | 0.21% | 90 |
|
|
2021
Q3 | $1.07M | Sell |
7,392
-1,519
| -17% | -$221K | 0.21% | 116 |
|
|
2021
Q2 | $1.18M | Sell |
8,911
-1,091
| -11% | -$144K | 0.22% | 106 |
|
|
2021
Q1 | $1.28M | Buy |
+10,002
| New | +$1.28M | 0.25% | 94 |
|